These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 24882258)
1. High levels of CD160 expression up-regulated counts of chronic lymphocytic leukemia cells and were associated with other clinical parameters in Chinese patients with chronic lymphocytic leukemia. Zhang ZH; Chen S; Chen S; Liu Y; Qu JH Leuk Lymphoma; 2015 Feb; 56(2):529-32. PubMed ID: 24882258 [No Abstract] [Full Text] [Related]
3. CD160 receptor in CLL: Current state and future avenues. Oumeslakht L; Aziz AI; Bensussan A; Ben Mkaddem S Front Immunol; 2022; 13():1028013. PubMed ID: 36420268 [TBL] [Abstract][Full Text] [Related]
5. Differential and tumor-specific expression of CD160 in B-cell malignancies. Farren TW; Giustiniani J; Liu FT; Tsitsikas DA; Macey MG; Cavenagh JD; Oakervee HE; Taussig D; Newland AC; Calaminici M; Bensussan A; Jenner M; Gribben JG; Agrawal SG Blood; 2011 Aug; 118(8):2174-83. PubMed ID: 21715317 [TBL] [Abstract][Full Text] [Related]
6. T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production. Riches JC; Davies JK; McClanahan F; Fatah R; Iqbal S; Agrawal S; Ramsay AG; Gribben JG Blood; 2013 Feb; 121(9):1612-21. PubMed ID: 23247726 [TBL] [Abstract][Full Text] [Related]
7. Combination of CD160 and CD200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B-cell neoplasms. Lesesve JF; Tardy S; Frotscher B; Latger-Cannard V; Feugier P; De Carvalho Bittencourt M Int J Lab Hematol; 2015 Aug; 37(4):486-94. PubMed ID: 25470765 [TBL] [Abstract][Full Text] [Related]
8. CD69 is independently prognostic in chronic lymphocytic leukemia: a comprehensive clinical and biological profiling study. Del Poeta G; Del Principe MI; Zucchetto A; Luciano F; Buccisano F; Rossi FM; Bruno A; Biagi A; Bulian P; Maurillo L; Neri B; Bomben R; Simotti C; Coletta AM; Dal Bo M; de Fabritiis P; Venditti A; Gattei V; Amadori S Haematologica; 2012 Feb; 97(2):279-87. PubMed ID: 21993667 [TBL] [Abstract][Full Text] [Related]
9. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Del Poeta G; Maurillo L; Venditti A; Buccisano F; Epiceno AM; Capelli G; Tamburini A; Suppo G; Battaglia A; Del Principe MI; Del Moro B; Masi M; Amadori S Blood; 2001 Nov; 98(9):2633-9. PubMed ID: 11675331 [TBL] [Abstract][Full Text] [Related]
10. Quantitative evaluation of CD52 expression in B-cell chronic lymphocytic leukemia. D'Arena G; Vigliotti ML; Matera R; Musto C; Iodice G; Tartarone A; Di Renzo N Leuk Lymphoma; 2003 Jul; 44(7):1255-7. PubMed ID: 12916884 [No Abstract] [Full Text] [Related]
11. CD200 Expression in Diagnostic and Prognostic Assessment of Mature B Cell Lymphophoproliferative Neoplasms. El Din Fouad NB; Ibrahim NY; Abdel Aziz RS; Ibrahim SK Asian Pac J Cancer Prev; 2018 Dec; 19(12):3383-3392. PubMed ID: 30583344 [TBL] [Abstract][Full Text] [Related]
12. Total expression of HLA-G and TLR-9 in chronic lymphocytic leukemia patients. Własiuk P; Tomczak W; Zając M; Dmoszyńska A; Giannopoulos K Hum Immunol; 2013 Dec; 74(12):1592-7. PubMed ID: 23994589 [TBL] [Abstract][Full Text] [Related]
13. Polymorphisms and haplotypes in multidrug resistance 1 gene are not associated with chronic lymphocytic leukemia susceptibility and prognostic parameters of chronic lymphocytic leukemia in Chinese population. Dong HJ; Miao KR; Qiao C; Zhuang Y; Shen WY; Hong M; Fan L; Liu P; Xu W; Li JY Leuk Lymphoma; 2011 Jun; 52(6):1003-9. PubMed ID: 21463115 [TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease detection with tumor-specific CD160 correlates with event-free survival in chronic lymphocytic leukemia. Farren TW; Giustiniani J; Fanous M; Liu F; Macey MG; Wright F; Prentice A; Nathwani A; Agrawal SG Blood Cancer J; 2015 Jan; 5(1):e273. PubMed ID: 25615279 [TBL] [Abstract][Full Text] [Related]
15. CD38 modifications in chronic lymphocytic leukemia: are they relevant? Ghia P; Guida G; Scielzo C; Geuna M; Caligaris-Cappio F Leukemia; 2004 Oct; 18(10):1733-5. PubMed ID: 15343349 [No Abstract] [Full Text] [Related]
16. Expression of the chemokine receptors CXCR4 and CCR7 and disease progression in B-cell chronic lymphocytic leukemia/ small lymphocytic lymphoma. Ghobrial IM; Bone ND; Stenson MJ; Novak A; Hedin KE; Kay NE; Ansell SM Mayo Clin Proc; 2004 Mar; 79(3):318-25. PubMed ID: 15008605 [TBL] [Abstract][Full Text] [Related]
17. CD160 isoforms and regulation of CD4 and CD8 T-cell responses. El-Far M; Pellerin C; Pilote L; Fortin JF; Lessard IA; Peretz Y; Wardrop E; Salois P; Bethell RC; Cordingley MG; Kukolj G J Transl Med; 2014 Sep; 12():217. PubMed ID: 25179432 [TBL] [Abstract][Full Text] [Related]
18. High Levels of CD244 Rather Than CD160 Associate With CD8 Wang X; Wang D; Du J; Wei Y; Song R; Wang B; Qiu S; Li B; Zhang L; Zeng Y; Zhao H; Kong Y Front Immunol; 2022; 13():853522. PubMed ID: 35386693 [TBL] [Abstract][Full Text] [Related]